CURE Pharmaceutical Holdings

CURE Pharmaceutical Holdings (OTCQB: CURR) has secured $10 million in financing through the issuance of convertible notes. The Oxnard, California-based company already raised $4 million under the first tranche of financing. CURE agreed to refund the commitment in cash only. Otherwise, notes are...

Pharmaceutical company CURE Pharmaceutical Holdings (OTCQB: CURR) agreed to acquire CBD products company Sera Labs Inc. for an up-front payment of $20 million. The price tag includes $1 million in cash and $19 million in CURE stock. The transaction, intended to occur in...